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Introduction of vegetable ingredients in fish feed has affected the fatty acid composition in farmed Atlantic salmon (Salmo salar L). Here we investigated how
changes in fish feed affected the metabolism of mice fed diets containing fillets from such farmed salmon. We demonstrate that replacement of fish oil with
rapeseed oil or soybean oil in fish feed had distinct spillover effects in mice fed western diets containing the salmon. A reduced ratio of n-3/n-6 polyunsaturated
fatty acids in the fish feed, reflected in the salmon, and hence also in the mice diets, led to a selectively increased abundance of arachidonic acid in the
phospholipid pool in the livers of the mice. This was accompanied by increased levels of hepatic ceramides and arachidonic acid-derived pro-inflammatory
mediators and a reduced abundance of oxylipins derived from eicosapentaenoic acid and docosahexaenoic acid. These changes were associated with increased
whole body insulin resistance and hepatic steatosis. Our data suggest that an increased ratio between n-6 and n-3-derived oxylipins may underlie the observed
marked metabolic differences between mice fed the different types of farmed salmon. These findings underpin the need for carefully considering the type of oil
used for feed production in relation to salmon farming.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: EPA; DHA; Obesity; Diabetes; Aquaculture; Lipidomics1. Introduction
The beneﬁcial health effects of fatty ﬁsh such as salmon, herring
and mackerel, have largely been attributed to their high content of
marine n-3 PUFAs. Farmed Atlantic salmon has also been a rich source
of these fatty acids, as high amounts of ﬁsh oil (FO) and ﬁshmeal have
been used in the aquatic feed [1]. Such high use of marine ingredients
in ﬁsh feed in the rapidly growing global aquaculture industry is not
sustainable due to the stable harvest of wild ﬁsh stocks as 3–5 kg fresh⁎ Correspondence to: K. Kristiansen, Department of Biology, University of
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0955-2863/© 2015 The Authors. Published by Elsevier Inc. This is an open access article under tﬁsh were previously used to produce 1 kg farmed ﬁsh [2]. Hence,
marine ingredients are increasingly replaced with vegetable ingredi-
ents in the ﬁsh feed used in commercial production [3]. This
replacement alters fatty acid composition in the commercially
available salmon ﬁllets [4,5], and therefore, the potential spillover
effects on consumers warrant further investigation. We have shown
that replacement of FO with vegetable oils, soy bean oil (SO) in
particular, inﬁsh feed leads to a reducedn-3/n-6 PUFA ratio both in the
salmonﬁllets and in redblood cells collected frommice consuming the
salmon [6,7]. Of note, the reduced n-3/n-6 ratio in mice given the SO
fed salmon was accompanied by increased insulin resistance and
hepatic fat accumulation [7].
Whether there is a causal link between non-alcoholic fatty liver
disease (NAFLD) and insulin resistance is a controversial question
[8–10]. However, NAFLD and insulin resistance often co-occur, and
both NAFLD and insulin resistance are strongly related to inﬂamma-
tion [11–13]. The role of inﬂammatory mediators, such as diacylglyc-
erols (DAG) and ceramides, in modulating ectopic lipid accumulation
involved in the development of insulin resistance is not fully
elucidated, but ceramides are suggested to be key intermediateshe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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inﬂammatory cytokines, like tumor necrosis factor-α (TNF-α) to the
induction of insulin resistance [14–16]. It is likely that insulin
resistance and hepatic fat accumulation observed in mice given SO
fed salmon compared with mice fed FO fed salmon [7], are related to
the fatty acid composition in the salmon, and consequently, the mice
feed. Of note, a low n-3/n-6 ratio has been associated with
development of NAFLD [17] and n-3 PUFAs have been proposed as a
therapeutic intervention in the treatment of NAFLD [18]. The n-3
PUFAs, EPA and DHA, are suggested to reduce accumulation of hepatic
triacylglycerols (TAG) by increasing fatty acid oxidation and sup-
pressing de novo lipogenesis and TAG formation [19–21]. Moreover, n-
3 PUFAs might ameliorate NAFLD-progression and development of
insulin resistance by their anti-inﬂammatory properties. The ability of
n-3 PUFAs to inhibit diet-induced inﬂammation and insulin resistance
is demonstrated to be, at least in part, mediated by their ability to
activate the GPR120 receptor [22], but a number of additional
mechanisms likely plays a role. EPA and DHA may inhibit arachidonic
acid (AA)-dependent prostanoid production by incorporation into
membrane phospholipids, reducing the amount of AA available as a
substrate for cyclooxygenases. At the same time, the n-3 PUFAs serve as
substrates for conversion to prostanoids of the 3- and 5-series that are
considered less pro-inﬂammatory than AA-derived prostanoids [23],
and n-3-epoxides which are reported to have anti-nociceptive [24],
anti-angiogenic and anti-tumorogenic properties [25]. The n-3 PUFAs
are also used as substrates for production of the anti-inﬂammatory
resolvins and protectins [26]. Of note, resolvin E1 and protectin D1have
been demonstrated to mimic the insulin-sensitizing and anti-steatotic
effects of n-3 PUFAs in animal studies [27]. Competition between n-3
PUFAs and AA for incorporation into phospholipids furthermore
reduces substrate availability for syntheses of the two major endoge-
nous endocannabinoids 2-arachidonoylglycerol (2-AG) and N-arachi-
donoylethanolamine (AEA) [28,29]. Given the importance of the
cannabinoid receptor CB1 in development of diet-induced steatosis
and insulin-resistance in mice [30,31], this represents an additional
mechanism by which the levels of dietary n-3 and n-6 PUFAs can
inﬂuence the development of hepatic steatosis and insulin resistance.
Since it is likely that the fatty acid composition is playing a key role
in the metabolic effects we observed in mice fed salmon raised on
different vegetable oil sources, We hypothesized that changes in
hepatic neutral lipids, phospholipids and oxylipin, endocannabinoid
and ceramide proﬁles, at least in part, contributed to hepatic lipid
accumulation and the metabolic phenotypes. Accordingly, to investi-
gate the molecular changes concurrent with and possibly involved in
hepatic lipid accumulation, we evaluated changes in the liver
lipidome. Speciﬁcally, we measured fatty acid proﬁles, lipid classes,
phospholipids, oxylipins, endocannabinoid and ceramide proﬁles in
combination with histological and molecular biological analysis of
mice fed aWestern diet (WD) containing either Atlantic salmon fed FO
or Atlantic salmon where a high proportion of the FO was replaced
with SO or rapeseed oil (RO).
2. Materials and methods
2.1. Ethical Statement
Animal handling and experiments were performed in accordance with the
guidelines of the Norwegian Animal Research Authority (NARA) (Norwegian approval
identiﬁcation nr, FOTS Id:3196).
2.2. Experimental diets
Atlantic salmon were produced as described earlier [4]. All feed ingredients except
the oil were the same and these are listed in [4]. The oil were either 100 % ﬁsh oil (FO) or
20% FO+80% rapeseed oil (RO), or 20% FO+80% soybean oil (SO). Fish ﬁllets were
subsequently freeze dried, and included in Western-diets (WD) as described [7].
Formulations of themice dietswere based on the standardWestern diet (WD)D12079B
Research diets, Inc. NJ, USA and prepared by Ssniff Spezialdiäten (Soest, Germany). Wereplaced 50% of the protein source in the standard WD with proteins from salmon fed
FO, RO or SO. As references two groups of mice were fed a regular low fat diet (LF),
D12450B Control Diet or a WD where 50% of the protein source was replaced with
proteins from chicken breast ﬁlets. Chicken was chosen as a control since WD
containing casein resulted in a lower fat digestibility compared with salmon fed FO [7].
Fat digestibility was equal for all mice fed the different WDs (Table S3).2.3. Animals
Fifty male C57BL/6J BomTac mice were obtained from Taconic (Ejby, Denmark) at 8
weeks of age. Themice weremaintained in a controlled environment with an artiﬁcial 12-
h-light/dark cycle. To avoid thermal stress [32],micewerekept at thermoneutrality (30°C).
Mice were allowed to acclimatize on a regular LF diet for 5 days. After acclimatization, the
mice were housed individually and assigned by weight and body composition to the
experimental diets. The mice had free excess to tap water and were fed the experimental
diets described in Table S1 for 10 weeks ad libitum. Throughout the experiment, all mice
were weighed once a week and feed intake was assessed every Monday, Wednesday and
Friday. Leanmass and fatmasswere determined prior to the feeding trial, and after 6 and 9
weeks by using nuclear magnetic resonance (NMR) (Minispec mq 7.5, NMR analyzer,
Bruker, Germany). After a 10 weeks feeding period, mice were euthanized in fed state by
cardiac puncture under Isoﬂurane anesthesia (Isoba-vet, Schering-Plough, Denmark).
Liver, muscle and adipose tissue depots were quickly dissected out, weighed, snap-frozen
in liquid nitrogen and stored at−80°C for further analysis. Blood was collected in EDTA-
coated tubes, and plasma was prepared by centrifugation and stored in aliquots at−80°C
for further use. Sampling was performed at room temperature (20°C).2.4. Tissue and plasma analyses
Circulating insulin was measured in plasma using ELISA kit (EIA-3440, DRG
International, INC., USA). Producer manuals were followed for measurements. Total
RNA was isolated from mouse tissue using Trizol (Invitrogen). Reverse transcription
was performed and cDNA was analyzed by qPCR using Light cycler 480 (Roche,
Germany) as earlier described [33]. Fatty acid composition wasmeasured in the neutral
and phospholipid pools fractionated from liver samples as described earlier [6].2.5. Histology
Liver was dissected out, ﬁxed in 4% formaldehyde overnight, and stored in 0,1 M
phosphate buffer before dehydration. Dehydration, parafﬁn embedding and sectioning
were performed at Molecular Imaging Center (MIC) at the University of Bergen.
Dehydration was performed by using Leica TP1020, Automatic Tissue Processor, 2 h in
each container. The samples were cut into 5 μm-thick sections, and stained with
Hematoxylin-Eosin for morphology investigations. For oil red O staining, samples
were treated with a sucrose solution (20%) overnight before being stored in tissue
tech at −80°C. Samples were cut into 10 μm-thick sections (CM 1950 Cryostat, Leica
Biosystems, Germany), and stained with oil red O.2.6. Targeted metabolomics
Liver Fatty Acids: Frozen liver samples were weighed (~20 mg) and placed in 5 μl
anti-oxidant solution (0.2 mg/mL butylated hydroxytoluene (BHT)/EDTA) and 10 μL of a
solution containing analytical surrogates were added to correct for extraction losses and
ion suppression. Lipids were extracted from the liver subsamples via stepwise solvent
extraction, using a modiﬁed protocol previously described [34]. After treatment with
sodiummethoxide/methanolic HCl, fatty acid methyl esters were analyzed by an Agilent
6890 Plus+equipped with 7683 Injector using a DB-225MS (30m× 0.25 mm× 0.25 μm)
column and detected by GC5973N mass selective detector. Conditions: 1 μL splitless
injection, SIM/SCANmodedata collection; ColumnFlow:1mL/min for 5min,+0.25mL/min
rampto3.5mL/min, 4mL/min for28min,2mL/min for2min;OvenTemperature: 65°C for
1 min, +35°C/min to 195°C, hold 0.5 min, +3°C/min to 235°C, +5°C/min to 240°C,
hold 23.5 min, cool to 65°C in 2 min. SIM data was used for quantiﬁcation against a
6-point calibration curve.
Liver Metabolite Acquisition: Non-esteriﬁed oxylipin, endocannabinoid and
ceramides and their associated surrogates were analyzed by LC-MS/MS [35,36] from
an aliquot of the stepwise extract described above. Additionally, esteriﬁed oxylipins
within extracts were released by hydrolysis with 0.5 M sodium methoxide for 1 h at
60°C. Non-esteriﬁed oxylipinswere isolated from total lipid extracts using a solid-phase
extraction protocol with Oasis HLB columns (Waters, USA). Oxylipins were separated
with a 16 min reverse phase gradient on a 2.1×150 mm, 1.7 μm Acquity BEH column at
60°C on aWaters Acquity UPLC. Analyteswere ionized in negativemode by electrospray
ionization (ESI) and datawas acquired and collected inmulti-reactionmonitoringmode
(MRM) with an AB Sciex 4000QTRAP tandem mass spectrometer. Endocannabinoids
were separated on the same UPLC column and mobile phases but were ionized in
positivemode by ESI in an independent 11min run. Ceramideswere separated on a BEH
C8, 2.1×100 mm column and were ionized in positive mode by ESI with a 15 min run
time, modiﬁed for UPLC from published methods [36].
Table 1
Activity indices from esteriﬁed fatty acids in liver.
Fatty Acid
Indices
Ratio WD-FO WD-RO WD-SO WD-chicken
ELOVL 18:0/C16:0 0.30±0.09 a 0.18±0.04 b 0.15±0.05 b 0.12±0.03 b
SCD 18:1n-9/18:0 3±1 a 8±3 a,b 10±4 b 15±4 b,c
SCD 16:1n-7/16:0 0.15±0.08 a 0.24±0.09 a,b 0.31±0.08 b 0.41±0.08 b,c
Results are presented as mean±SD (n=6). Different letters (a, b) indicate statistical
signiﬁcance of pb0.05.
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Data in Tables 1–4 and S4 and Fig. 6 were tested by 1-way ANOVA with Tukey’s
post-hoc test formultiple comparisons (XLSTAT Version 2013.5.06). The rest of the data
was tested by 1-way ANOVA with Fisher LSD post-hoc test using Statistica version 11
(StatSoft, USA). Non-parametric Kruskal-Wallis test was performed where the
assumptions for parametric tests were not met. Data were considered signiﬁcant
when pb0.05.
PCA-plot: The complete data set contained 357 variables, 8568 data points and 178
zeroes. Data were transformed to normal and missing values were imputed using
probabilistic principal components analysis (PCA) [37] for a ﬁnal data set of 8745 data
points (1 zero) in imDEVv 1.4.2, an R-basedmultivariate statistical add-in for Excel [38].
Low fat fed animals were not included in any statistical modeling or statistical
calculations. The PCA used to assess group discrimination were performed by NIPALS
using 4 principal components, mean centering and univariate scaling with the
normalized and imputed data set. Best separation of treatment groups was observed
in PC1 vs. PC3, explaining 39% of the total variance.
3. Results
3.1. Mice fed WD-SO are more insulin resistant and have higher hepatic
lipid accumulation than mice fed WD-FO
To investigate the spillover effects of replacing ﬁsh oil with
vegetable oils in ﬁsh feed, we fed mice WD containing ﬁllets from
salmon fed either ﬁsh oil (WD-FO) or a high proportion of rapeseed oil
(WD-RO) or soybean oil (WD-SO). A standard low fat chow diet (LF)
was used as a reference. Since we have observed reduced digestibility
of fat in mice fed standardWD based on casein as a protein source [7],
chicken ﬁllet was chosen as the protein source in a control Western
diet (WD-chicken). After 10weeks of feeding, feed intake,weight gain,
energy efﬁciency and fat digestibility were similar in all WD fed mice
(Table S3). However, nuclear magnetic resonance (NMR) analysis
revealed a signiﬁcantly higher fat mass and lower lean body mass in
WD-SO fed mice after 6 and 9 weeks of feeding compared with mice
fedWD-FO (Fig. 1). In agreementwith our earlier study [7], an ITT after
7 weeks of feeding showed reduced insulin sensitivity in mice fed the
WD-SO compared with mice fed the WD-FO (Fig. S1A). Of note,
comparedwith the LF fedmice,WD-SO andWD-chicken fedmice hadTable 2
Ceramides measured in mouse liver.
Ceramides (nM) WD-FO WD-RO
18:1 Sphingosin1P 408±90 368±
18:1 Sphingosine 15,800±1800 16,600±
C14 Ceramide 359±112 a 527±
C16 Ceramide 7200±1200 a 8830±
C18 Ceramide 645±160 706±
C18:1 Ceramide 297±75 a 468±
C20 Ceramide 2030±300 1940±
C24 Ceramide 30,400±6100 23,200±
C18 dihydroceramide 108±55 76±
C24 dihydroceramide 512±62 475±
Results are presented as mean±SD (n=6). Different letters (a, b) indicate statistical signiﬁcansigniﬁcantly reduced insulin sensitivity calculated as AUC after 30 and
60 min (Fig. S1B and C). Compared with LF fed mice, insulin levels in
the fed state were signiﬁcantly higher only in WD-SO fed mice
(Fig. S1D). As expected, the levels of fatty acids inhepatic neutral lipids
(NL) were increased in mice fed WD-SO, WD-RO and WD-chicken
compared with WD-FO (Fig. 2A), whereas the levels of fatty acids in
the polar lipid pool were similar (Fig. 2B).With the exception ofWD-
FO fed mice, the total level of fatty acids in liver was higher than 5%, an
indication of NAFLD [39], in all WD fedmice (Fig. 2C). The hepatic level
of free cholesterol was higher in mice given WD-SO and WD-chicken
compared with mice given WD-FO, however, there was no difference
between mice fed WD-RO and WD-FO (Fig. 2D). Interestingly,
compared to WD-FO fed mice, hepatic levels of diacylglycerol
(DAG), suggested as a link to insulin resistance [40], and TAG were
increased in all other WD fed mice (Fig. 2E and F).
Hematoxylin and eosin (H&E) staining was performed to visualize
the accumulation of lipids in liver (Fig. 2G). In agreementwith the lipid
analyses, few lipid droplets were observed in WD-FO fed mice,
whereas high numbers of lipid droplets were observed in WD-SO and
WD-chicken fed mice. Oil red O (ORO) staining conﬁrmed that the
droplets contained neutral lipids (Fig. 2H). The fat accumulation in the
liver ofWD-SO andWD-chicken fedmice was accompanied by higher
expression of the hepatic steatosis marker genes, Serpine1, Pparg and
Plin2 (Fig. 3A).
Plasma levels of alanine aminotransferase (ALT) tended to be
elevated in WD-SO and WD-chicken fed mice (Fig. 3B), and together
our ﬁndings indicate that hepatic steatosis was induced in mice fed
WD-SO and WD-chicken. However, whereas the increased accumu-
lation of fat in liver frommice fedWD-chicken was accompanied by a
signiﬁcantly increased expression of the inﬂammatory markers, Tnf,
Emr1, Cd68 and Ccl2, only Ccl2 was signiﬁcantly higher expressed in
WD-SO fed mice compared with WD-FO fed mice (Fig. 3C).
3.2. Expression of genes involved in fatty acid uptake and synthesis is
higher in livers from WD-SO than WD-FO fed mice
To investigate possible mechanisms underlying the differences in
hepatic lipid accumulation, expression of genes involved in fatty acid
uptake, synthesis and oxidation was measured. Compared with WD-
FO fed mice, expression of genes involved in fatty acid uptake (Cd36,
Lpl, Cav1, Slc27a5 and Fabp1) was increased in the other WD fed mice
(Fig. 4A). Expression levels of genes involved in fatty acid oxidation
were not elevated in mice fed WD-FO compared with the other WDs
(Fig. S2A). However, several genes involved in hepatic lipid synthesis
(Lxr, Srebpf1, Acaca, Fasn, and Scd1) were expressed at lower levels in
mice fed WD-FO compared with the other WD-fed mice (Fig. 4B). Of
note, none of the measured genes were expressed at signiﬁcantly
different levels in theWD-SO andWD-chicken fedmice. Expression ofWD-SO WD-chicken
140 416±140 312±110
1600 18,000±2500 18,400±2300
194 a,b 663±169 b 670±120 b
2300 a,b 10,900±2800 b 11,100±1500 b
170 749±350 818±140
170 a,b 604±170 b 702±150 b
320 2400±550 2000±500
4300 26,300±6000 22,300±7200
27 85±30 78±25
100 563±130 547±190
ce of pb0.05.
Table 3
Endocannabinoids measured in mouse liver.
Endocannabinoids (nM) Parent fatty acid WD-FO WD-RO WD-SO WD-chicken
PEA 16:0 177±68 154±61 170±48 176±65
SEA 18:0 209±140 a 80±43 a,b 98±55 a,b 53±62 b
1-OG 18:1n-9 11,700±4900 9200±4900 5900±3300 8100±1600
OEA 18:1n-9 47±37 48±39 50±46 38±21
1-LG 18:2n-6 3790±3100 2710±1400 3080±910 2600±3300
2-LG 18:2n-6 11,400±6000 8400±1900 14,200±1200 9200±3000
LEA 18:2n-6 7±4 16±13 18±17 9±6
aLEA 18:3n-3 2±2 a 0.8±0.4 a,b 0.6±0.4 a,b 0.3±0.3 b
Dihomo GLA EA 20:3n-6 0.3±0.2 0.8±0.4 1.2±0.4 1±1
1-AG 20:4n-6 355±260 164±29 217±35 293±140
2-AG 20:4n-6 1420±600 1050±200 1550±530 1650±790
AEA 20:4n-6 2±2 3±3 4±3 4±3
DEA 22:5n-3 0.3±0.3 0.2±0.1 0.3±0.3 0.18±0.07
DHEA 22:6n-3 9±6 a 4±2 a,b 5±3 a,b 3±2 b
Results are presented as mean±SD (n=6). Different letters (a, b) indicate statistical signiﬁcance of pb0.05.
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mice andMtpwas expressed at signiﬁcantly lower levels inWD-FO fed
mice compared with mice given WD-SO (Fig. S2B).
Together, the qPCR- analyses indicated that fatty acid uptake and
synthesis were higher in liver from WD-SO than WD-FO fed mice. ToTable 4
Non-esteriﬁed oxylipins measured in mouse liver.
Non-esteriﬁed oxylipins (nM) Parent fatty Acid Metabolite class
TXB2 C20:4n6 Thromboxane
PGD2 C20:4n6 Prostaglandin
PGF2a C20:4n6 Prostaglandin
9,12,13-TriHOME C18:2n6 Triol
9,10,13-TriHOME C18:2n6 Triol
12,13-DiHOME C18:2n6 Diol
9,10-DiHOME C18:2n6 Diol
15,16-DiHODE C18:3n3 Diol
9,10-DiHODE C18:3n3 Diol
14,15-DiHETrE C20:4n6 Diol
11,12-DiHETrE C20:4n6 Diol
8,9-DiHETrE C20:4n6 Diol
5,6-DiHETrE C20:4n6 Diol
17,18-DiHETE C20:5n3 Diol
14,15-DiHETE C20:5n3 Diol
19,20-DiHDoPA C22:6n3 Diol
8,15-DiHETE C20:5n3 Diol
13-HODE C18:2n6 Alcohol
9-HODE C18:2n6 Alcohol
13-HOTE C18:3n3 Alcohol
9-HOTE C18:3n3 Alcohol
15-HETrE C20:3n6 Alcohol
20-HETE C20:4n6 Alcohol
15-HETE C20:4n6 Alcohol
12-HETE C20:4n6 Alcohol
11-HETE C20:4n6 Alcohol
9-HETE C20:4n6 Alcohol
8-HETE C20:4n6 Alcohol
5-HETE C20:4n6 Alcohol
15-HEPE C20:5n3 Alcohol
12-HEPE C20:5n3 Alcohol
5-HEPE C20:5n3 Alcohol
17-HDoHE C22:6n3 Alcohol
14-HDoHE C22:6n3 Alcohol
13-KODE C18:2n6 Ketone
9-KODE C18:2n6 Ketone
15-KETE C20:4n6 Ketone
12(13)-EpOME C18:2n6 Epoxide
9(10)-EpOME C18:2n6 Epoxide
15(16)-EpODE C18:3n3 Epoxide
9(10)-EpODE C18:3n3 Epoxide
14(15)-EpETrE C20:4n6 Epoxide
11(12)-EpETrE C20:4n6 Epoxide
17(18)-EpETE C20:5n3 Epoxide
11(12)-EpETE C20:5n3 Epoxide
19(20)-EpDPE C22:6n3 Epoxide
12(13)-Ep-9-KODE C18:2n6 Epoxy Ketone
Results are presented as mean±S.D. (n=6). Different letters (a, b) indicate statistical signiﬁcainvestigate this further, the levels of individual fatty acids were
measured in both mouse feed and in the neutral and polar liver lipid
pool. The n-3/n-6 ratio in mouse liver reﬂected the n-3/n-6 ratio in
feed (Fig. 4G). Moreover, in both fractions, accumulation of EPA
(Fig. 4C), DHA (Fig. 4D) and LA (Fig. 4E), but not AA (Fig. 4F) mirroredWD-FO WD-RO WD-SO WD-chicken
94±73 98±78 86±46 109±44
20±3 22±9 26±12 42±24
27±11 a 35±9 a,b 36±12 a,b 78±71 b
71±27 65±25 63±16 73±30
58±21 47±17 59±15 59±25
23±10 39±22 50±26 30±15
150±55 286±156 461±333 269±154
6±2 11±7 13±8 6±1
1.3±0.3 a 3±1 b 3±2 a,b 1.2±0.6 a,c
36±9 46±17 65±31 75±43
19±5 23±8 35±20 34±20
10±3 12±5 23±15 19±11
3±2 4±2 7±6 6±4
1010±290 a 680±180 a,b 500±180 b 147±60 c
1410±520 a 955±280 a,b 790±360 b 187±110 c
101±36 85±52 77±30 44±21
6±2 7±3 6±1 7±3
243±120 362±270 429±270 391±280
58±24 85±68 106±63 97±73
4±2 9±6 6±3 5±3
3±1 a,b 6±4 a 5±3 a 1,9±0,7 b
8±2 13±7 21±12 23±16
19±6 14±5 22±10 20±9
13±4 16±11 22±11 36±27
198±146 379±485 440±435 770±835
7±3 9±9 13±9 22±20
4±3 4±4 5±4 7±4
5±2 4±4 8±6 9±7
11±8 10±6 12±5 16±7
36±16 a 19±6 b 17±8 b 7±5 b
1390±780 1490±1500 900±700 260±250
30±14 a 17±10 a 14±7 a 5±2 b
51±18 a 32±12 a,b 29±13 a,b 20±13 b
363±180 345±250 270±190 170±160
11±3 10±7 14±7 12±7
3±1 a 5±2 a,b 6±2 b 4±2 a,b
0.9±0.5 1.1±0.8 1.5±0.8 3±2
3±1 3±2 4±1 2±2
1.1±0.5 0.9±0.7 1.2±0.7 1.1±0.5
1.6±0.7 a,b 3±2 a,b 4±2 a 1.1±0.8 b
0.4±0.1 0.4±0.2 0.3±0.1 0.3±0.1
0.7±0.2 0.6±0.5 0.8±0.2 0.9±0.4
1.2±0.9 1.4±0.8 1.6±0.6 2±1
11±7 a 7±5 a 4±2 a 0.9±0.7 b
0.7±0.4 a 0.4±0.2 a,b 0.4±0.2 a,b 0.09±0.07 b
18±3 a 13±6 a,b 14±9 a,b 7±3 b
4±2 5±2 5±2 4.6±0.9
nce of pb0.05.
Fig. 1. Body composition. Body composition was determined by Nuclear Magnetic
Resonance (NMR) at week 0, 6 and 9. Results are presented as mean±S.E.M. (n=10).
Different letters (a-c) indicate statistical signiﬁcance of pb0.05. Amount of free water is
not shown.
589L.K. Midtbø et al. / Journal of Nutritional Biochemistry 26 (2015) 585–595their respective levels in the diet. Although the level of AA in feed
was lower in WD-SO and WD-chicken than in WD-FO and WD-RO,
AA accumulated to higher levels in the polar lipids. While dietary
LA may be converted to AA, the incorporation of AA into
phospholipids is competitively inhibited by n-3 PUFAs [28]. The
increased accumulation of AA in phospholipids was accompanied
by low n-3/n-6 PUFA ratio in WD-SO and WD-chicken diets
(Fig. 4G). Thus, it is conceivable that reduced competition from
n-3 PUFAs allowed a higher incorporation of AA into phospholipids
in these mice.
NAFLD is associated with increased hepatic levels of saturated
fatty acids like palmitic acid (PA) and monounsaturated fatty
acids like oleic acid (OA) [41]. Compared with WD-FO mice, both
PA and OA accumulated to higher levels in the liver neutral lipids
in the other WD-fed mice (Fig. 4H and I). Similarly, the levels of
total saturated fatty acids were lower in WD-FO fed mice (Fig. 4J).
Accumulation of these fatty acids did not reﬂect dietary level.
Thus, the accumulation of PA and OA in the WD-SO and WD-
chicken fed mice is likely to originate from increased hepatic fatty
acid synthesis. This is in line with a higher expression of genes
involved in lipogenesis, including stearoyl-CoA desaturase 1
(Scd1) in these mice.
Since it has been suggested that high levels of SCD1 is correlated
with disorders such as obesity and insulin resistance [42], SCD indices
from 16:1n-7/16:0 and 18:1n-9/18:0 ratios in the liver were
calculated to estimate a suite of activity indices. The SCD indices
calculated from both 16:1n-7/16:0 and 18:1n-9/18:0 ratios were
increased inWD-SO andWD-chicken comparedwithWD-FO fedmice
(Table 1).
Principal component analyses using the complete data set from all
analyses of mouse liver were visualized for 4 principal components,
revealing the best separation of treatments in PC1 vs PC3 (Fig. S3). Fig. 5
is a representation of the scores for PC1 and PC3, which illustrates
separation of each of the treatment groups, WD-FO, WD-RO, WD-SO
and WD-chicken. Data impacting separation of the groups on the
negative x-axis include the fatty acid index that is a surrogatemarker for
elongase of very long chain fatty acids (ELOVL) activity and 22:5n-3 in
the neutral lipid fraction of liver, leanmass atweek9measuredbyNMR,
and 20:5n-3 in the phospholipid fraction of liver. Data pulling the dataon the positive y-axis are several esteriﬁed fatty acids and oxylipins in
liver, including 22:5n-3, 18:3n-3, 12(13)-EpODE, 9(10)-EpODE, and20-
3n-3. Variables contributing to the separation of data towards the
negative y-axis include n-3 Sprecher pathway activity in liver, non-
esteriﬁed PGD2 and endocannabinoids (1-AG, PEA).
3.3. Mice fed the different WD had similar levels of 2-arachidonoylglycerol
(2-AG) and N-arachidonoylethanolamine (AEA) in the liver
It has been demonstrated that excessive dietary LA increases the
endocannabinoid tone in both salmon and in liver of mice consuming
the LA fed salmon as the sole protein source [6]. Here we observed a
tendency towards higher 2-AG levels in the liver of WD-SO compared
with WD-FO fed mice, but the difference was not statistically
signiﬁcant (Table 3). However, endocannabinoid-like compounds
stearoylethanolamide (SEA) (18:0 derived) and docosahexaenoyl
ethanolamide (DHEA) (DHA-derived) were both signiﬁcantly in-
creased in the WD-FO compared to the WD-chicken fed mice
(Table 3). Studies on DHEA have implied that DHEA oxidative
metabolism produces molecules with anti-inﬂammatory and organ
protective properties [43]. The high level of DHEA in mice fed WD-FO
is in line with the notion that omega-3 derived endocannabinoids
modulate inﬂammatory status [44].
3.4. Mice fed WD-SO had increased levels of ceramides compared with
WD-FO fed mice
Recent studies have reported that tissue ceramide synthesis is
modulated by several factors including hormones, inﬂammatory
molecules and saturated FAs [45]. Together, these factors may lead
to ceramide accumulation and further insulin resistance [46].
Ceramides measured in liver were altered by diet (Table 2). C14:0
ceramide, C16:0 ceramide and C18:1 ceramide were all ~2-fold higher
in the WD-SO fed mice compared to the WD-FO group. We also
evaluated correlations between the ceramides and the total esteriﬁed
saturated fatty acid pool (ΣSFA), andmRNA expression of Cd36 in liver
(data not shown). The C14:0, C16:0 and C18:0 - ceramide correlated
signiﬁcantly with Cd36 expression. In addition, C14, C16 and C18:1
ceramides were positively correlated with SFA. Taking these two
observations into account, the enriched ceramide pool in WD-SO fed
mice and the positive correlation between several ceramides and Cd36
expression and SFA pools, it appears that ceramides could contribute
to the metabolic effects observed in the WD-SO fed mice.
3.5. WD-FO fed mice had lower levels of oxylipins derived from LA and
AA in liver
Oxylipins are a broad group of oxygenated polyunsaturated lipids
that include the twenty carbon eicosanoids (prostaglandins, leukotri-
enes and thromboxanes) along with many other classes of metabo-
lites, including alcohols, ketones, epoxides, and diols. Importantly,
eicosanoid imbalances have been associated with chronic inﬂamma-
tion, arterial hypertension, coronary heart disease, atherosclerosis and
diabetes mellitus [47]. We measured both esteriﬁed and non-
esteriﬁed oxylipins in liver. Esteriﬁed oxylipins derived from LA
were highest in mice fed WD-SO (Fig. 6A) and alterations in oxylipins
from ALA metabolism were observed (Fig. 6B). Several of the
membrane-bound oxylipins derived from AA were elevated (Fig. 6C)
in the WD-SO group relative to the WD-FO fed mice, which include:
PGF2α (~3-fold), 15-HETE (~2-fold), 5-HETE (~2-fold) and 15-KETE
(~2-fold). EPA and DHA oxylipin metabolism in mice was also altered
by diet (Fig. 6D and E). Oxylipins derived from EPA were signiﬁcantly
higher in theWD-FO group than all other groups. Oxylipins measured
in the non-esteriﬁed pool are presented in Table 4, and include
thromboxanes and PGD2 that are unstable in the alkaline-hydrolysis
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Fig. 2. Hepatic lipid accumulation. Total hepatic level of fatty acids in neutral lipids (NL) (A)
(C).Hepatic level of free cholesterol (D), diacylglycerol (DAG) (E) and triacylglycerol (TAG) (F).
signiﬁcance of pb0.05. Hematoxylin and eosin (H&E) staining of liver sections (G). Oil red O
magniﬁcations, scale bar=100 μm.
Fig. 3. Liver steatosis and inﬂammation in liver. Expression of genes involved in liver
steatosis: Serpine1, Pparg and Plin2 (A). Plasma levels of alanine transaminase (ALT) (C).
Expression of genes involved in inﬂammation measured in liver: Tnf, Emr1, Cd68 and
Ccl2 (B). Results are presented as mean±S.E.M. (n=10). Different letters (a-c) indicate
statistical signiﬁcance of pb0.05.
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signiﬁcant changes were observed in the non-esteriﬁed as compared
to the esteriﬁed pool, those observed paralleled the esteriﬁed pool,
including C20:5n3 derived 17,18-DiHETE; 14,15-DiHETE; 5-HEPE; and
17(18)-EpETE.4. Discussion
Replacement of ﬁsh oil with vegetable oils, soybean oil in
particular, in ﬁsh feed leads to a reduced n-3/n-6 PUFA ratio both in
salmonﬁllets and in redblood cells collected frommice consuming the
salmon [6,7]. In agreementwith an earlier study [7],wehere show that
mice fedWD-FOwere protected against diet-induced accumulation of
lipids in the liver, whereas fat accumulation exceeded 5% of liver
weight in control mice fed WD-chicken as well as in mice fed WD-RO
and WD-SO indicating NAFLD [39]. The hepatic accumulation of
neutral lipids (Fig. 2A) was accompanied by enlarged lipid droplets
supported by histological analysis (Fig. 2G and H) and increased
expression of the steatotic markers, Serpine1 and Pparg (Fig. 3A). A
low n-3/n-6 ratio has been associated with development of NAFLD
[17] and intake of n-3 PUFAs has been proposed as a therapeutic
intervention in the treatment of NAFLD [18]. The ﬁsh feed used to
produce the Atlantic salmon varied in the type of oils only. Thus, the
only difference in the mice diets originated from differences in the
salmon ﬁllets which reﬂected the different oil source used for the
preparation of the salmon feed. Salmon ﬁllet sterol composition was
similar in all salmon groups, but the levels of certain persistent organic
pollutants, such as polychlorinated biphenyls were reduced when ﬁsh
oils were replaced with vegetable oils [4,7,48]. The major consequence
of reducing the level of ﬁsh oil in the feed, however, was a reduced n-3/
n-6 ratio in the salmon ﬁllets and hence, in the mice diets, and in
isolated red blood cells collected from mice fed the different diets [7].
Hence, the differential effects are likely related to the fatty acid
composition, in particular the altered n-3/n-6 PUFA ratio, of the salmon.
A hallmark of ﬁsh oil and n-3 PUFA action is the ability to suppress
expression of genes involved in lipogenesis [49], and n-3 PUFAs are
suggested to reduce accumulation of hepatic TAG by increasing fatty
acid oxidation and suppressing de novo lipogenesis and TAG formation
[19–21]. Expression of genes involved in fatty acid oxidation was not
elevated in mice fed WD-FO. However, lower expression levels of
genes involved in de novo fatty acid syntheses, such as Fasn, Acaca and
Scd1 were observed in livers from WD-FO than in livers from WD-SO
fedmice (Fig. 4B). As administration of SEA is reported to decrease the
expression of Scd1 [50], the high level of SEA in the liver ofWD-FO fed
mice may contribute to the observed reduced expression of this gene.
Hepatic mRNA expression of Scd1 and the SCD liver fatty acid index
(C18:1n9/C18:0) were signiﬁcantly correlated. Further, while the
content of PA andOAwas comparable in theWD-FO andWD-SO diets,
less OA and PA accumulated in the neutral lipid pool in theWD-FO fed
mice (Fig. 4H and I). Finally, it is noteworthy that expression of genes
involved in fatty acid uptake was markedly increased in livers of WD-
chicken fed mice (Fig. 4A). Hepatic lipid accumulation results from an
imbalance between lipid uptake/synthesis and disposal that may
develop intoNAFLD [51]. Hence, n-3 PUFA-mediated inhibition of fatty
acid synthesis may, at least in part, contribute to the ability of WD-FO
to attenuate NAFLD.
Although theWD-SO feed contained 2.7 timesmore n-3 PUFAs than
the control WD-chicken, 7.6 and 2.8 mg/g, respectively (Table S2),
accumulation of fatty acids in hepatic neutral lipids was similar inWD-
SO and WD-chicken fed mice (Fig. 4A). WD-SO contained 5.9 timesand in polar lipids (PL) (B). The total level of fatty acids expressed as % of liver weight
Results are presented asmean±S.E.M. (n=10). Different letters (a-d) indicate statistical
(ORO) staining of cryosections of liver (H). Red stain indicates neutral lipids. 200×
Fig. 4. Fatty acid uptake, synthesis and oxidation in liver. Expression of genes involved in fatty acid uptake: Cd36, Lpl, Cav1, Slc27a5 and Fabp1 (A). Genes involved in lipid synthesis: Lxr,
Srebf1, Acaca, Fasn, Scd-1, Chrebp (B). Comparison between amount of different fatty acids in feed and in neutral lipids (NL) andpolare lipids (PL) in liver: EPA (C), DHA (D), LA (E), AA (F),
n-3/n-6 ratio (G), OA (H) PA (I) and SFA (H). Results are presented as mean±S.E.M. (n=10). Different letters (a-d) indicate statistical signiﬁcance of pb0.05.
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and 2.15 mg/g DHA in WD-SO compared with 0.19 and 0.22 mg/g,
respectively, inWD-chicken (Table S2). However, as the amount of LA is
high in the WD-SO, the n-3/n-6 ratios were comparable, 0.27 and 0.20,
respectively. Conversion of dietary LA to AA reportedly increases
competition between AA and the n-3 PUFAs, EPA and DHA [28]. In linewith this, the low n-3/n-6 ratio in the feed translated into a high
proportion of AA in liver PLs. Thus, despite a higher intake of n-3 PUFAs
in WD-SO than WD-chicken fed mice, the amount of AA in liver PL
was similar.
Both AA and n-3 PUFAs released from liver PLs may be converted
into lipidmediators, including endocannabinoids and eicosanoids that
Fig. 5. PCA-plot. PCA-scores of all data collected from mouse liver (n=6).
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Endocannabinoids reportedly contribute to both diet-induced insulin
resistance and steatosis [30,52] by activation of the cannabinoid-
receptor. An increased proportion of the n-3 PUFAs in liver PLs may
reduce the endocannabinoid tone by reducing the substrate availabil-
ity for formation of the AA derived endocannabinoids, 2-AG and AEA
[6,28] and increasing substrate availability for formation of the EPA
and DHA derived endocannabinoids, eicosapentaenoyl ethanolamide
(EPEA) and docosahexaenoyl ethanolamide (DHEA), respectively [53].
We have shown previously that increased levels of LA in salmon feed
increased the levels of endocannabinoids in both salmon and in the
mice consuming a high fat dietwhere 100% of the dietary proteinwere
replaced by salmon [6]. In order to limit the difference in fat
digestibility, we exchanged only 50% of the casein with proteins
from salmon in the present study. Although 50% exchange was
sufﬁcient to detect higher proportions of AA in PL from WD-SO than
WD-FO fed mice, we did not detect alterations in 2-AG and AEA levels
in the WD-SO fed mice (Table 3). However, the levels of DHEA,
suggested to have anti-inﬂammatory properties [53], tended to be
higher in WD-FO than WD-SO fed mice (Table 3).
Although NAFLD and insulin resistance frequently co-occur,
causality has been amatter of debate [9]. Still, inﬂammatorymediators
represent a link as they play a pivotal role in the development of both
NAFLD and insulin resistance [11–13]. Although the ability of n-3
PUFAs to inhibit diet-induced inﬂammation and insulin resistance is
demonstrated to be, at least in part, mediated by their ability to
activate the GRP120 receptor [22], their ability to modulate eicosa-
noid/oxylipin production by incorporation into membrane PLs is an
important feature for their anti-inﬂammatory properties [26]. In mice
deﬁcient for the group IVA PLA2, production of pro-inﬂammatory
eicosanoids is reduced, and these mice are protected against
diet-induced NAFLD [54]. Furthermore, both 12/15 LOX [55,56] and
COX-2 [57] play important roles in development of insulin resistance.
A higher proportion of EPA and DHA in membrane PLs reduces AA
availability anddecreases its competition for oxygenases including the
COXs and LOXs. The levels of oxylipins derived from the AA were
signiﬁcantly higher, while those derived from EPA and DHA were
signiﬁcantly lower in mice fed WD-SO than WD-FO. As oxylipins
derived from EPA and DHA are generally less pro-inﬂammatorycompared to those formed from AA [58], the increased content of EPA
and DHA in PLs may contribute to the improved insulin sensitivity
and decreased development of fatty liver in WD-FO fed mice
compared to the WD-SO group. A number of mediators classically
associated with inﬂammatory resolution, including PGD2 and the
DHA-derived 17-HDoHEwere detected in the non-esteriﬁed oxylipin
pool, with 17-HDoHE being signiﬁcantly inﬂuenced by diets
(Table 4). WD-FO mice had higher concentrations of 17-HDoHE
compared to WD-chicken fed animals. This DHA-derived precursor
to Resolvin D1 has been previously detected in liver, and is reported
to reduce inﬂammation [59].
TLR4 is suggested as an important link between nutrients,
inﬂammation and insulin resistance [60], and ceramides are required
for TLR4-dependent development of insulin resistance [61]. As
ceramides are reported to contribute to both NAFLD development
[62] as well as insulin resistance [16,61], the different ceramide levels
in liver (Table 2) from the different WD fed mice might have
contributed to their phenotypes. Of note, several groups have reported
correlations between diets rich in saturated fats with ceramide
production and insulin resistance [61,63–65]. However, whereas
insulin resistance induced by oleic acid and palmitic acid appears to
require ceramide synthesis, the unsaturated fatty acid, LA, induced
insulin resistance by DAG-mediated activation of PKCs in a
ceramide-independent manner [61]. These observations suggest
that DAG may participate in the regulation of insulin signaling by
polyunsaturated fatty acids, whereas ceramides may be more
important for the inhibition of insulin signaling by saturated fatty
acids. TheWD-SO had a higher amount of LA thanWD-FO, whereas
the amounts of saturated fat were comparable (Table S2). Never the
less, accumulation of saturated fatty acids in neutral lipids in WD-
SO fed mice was signiﬁcantly higher than in WD-FO fed mice
(Fig. 4J). Thus, it is conceivable that both the exacerbated
accumulation of DAG as well as increased levels of C14:0, C16:0
and C18:1 ceramides contributed to the increased hepatic lipid
accumulation observed in WD-SO fed mice compared to WD-FO
fed mice (Fig. 2A).
In conclusion, the present study conﬁrms our earlier ﬁnding that
intake of farmed Atlantic salmon fed soybean oil increases insulin
resistance and hepatic lipid accumulation inmice [7].We demonstrate
that fatty acid composition of the salmon feed and salmon ﬁllets elicits
characteristic changes in hepatic neutral lipids, phospholipids and
oxylipin proﬁles in the liver ofmice fed these different types of salmon
ﬁllets. The ratio of n-3/n-6 PUFAs seems to play an important role
determining the abundance of AA in the PL pool, and thereby
inﬂuences the source of fatty acids used for oxylipin synthesis. Our
data suggest that this change in the ratio between n-6 and n-3-
derived oxylipins may underlay the observed marked metabolic
differences between mice fed the different protein sources, and
possibly also the accumulation of ceramides in the livers of mice fed
WD-SO and WD-chicken. These ﬁndings underpin the need to
carefully consider the type of oil used for feed production in relation
to salmon farming.
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Fig. 6. Oxylipins in liver. Levels of esterﬁed oxylipins derived from LA (A), ALA (B), AA(C), EPA (D) and DHA (E). Results are presented as mean±S.D. (n=6). Different letters (a, b)
indicate statistical signiﬁcance of pb0.05.
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